Drugs such as the P2Y12 receptor blocker Ticagrelor, the modulator of selective estrogen receptor Tamoxifen and the inhibitor of sodium/glucose transporter-2 Empagliflozin can significantly increase the levels of eNOS in aortic tissues and correct RA-induced vascular responsiveness defects [75]. Here, NOS3 is linked to rheumatoid arthritis.